Penserra Capital Management LLC Amphastar Pharmaceuticals, Inc. Transaction History

Penserra Capital Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$44.49 - $62.93 $2.17 Million - $3.07 Million	48,749 New	48,749 $3.02 Million
Q2 2023 Aug 11, 2023	BUY	$35.77 - $58.38 $2.3 Million - $3.75 Million	64,291 New	64,291 $3.69 Million
Q2 2022 Aug 15, 2022	SELL	$29.79 - $42.29 $5.33 Million - $7.56 Million	-178,801 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$22.96 - $36.45 $4.11 Million - $6.52 Million	178,801 New	178,801 $6.42 Million
Q4 2021 Feb 15, 2022	SELL	$18.14 - $23.29 $19,954 - $25,619	-1,100 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$17.83 - $21.49 $267 - $322	15 Added 1.38%	1,100 $20,000
Q2 2021 Aug 12, 2021	BUY	$17.11 - $20.92 $256 - $313	15 Added 1.4%	1,085 $21,000
Q1 2021 May 13, 2021	SELL	$17.21 - $20.65 $344 - $413	-20 Reduced 1.83%	1,070 $19,000
Q4 2020 Feb 12, 2021	BUY	$17.76 - $21.24 $12,183 - $14,570	686 Added 169.8%	1,090 $21,000
Q3 2020 Nov 13, 2020	BUY	$17.99 - $22.22 $7,267 - $8,976	404 New	404 $7,000

280

36.7M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.64B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.